Prenuvo expands offerings with new health assessments, boosted by $120m funding

Deal News | Feb 13, 2025 | Felicis Ventures LLC

Prenuvo expands offerings with new health assessments, boosted by $120m funding

Prenuvo, a preventative health startup known for its comprehensive full-body MRI scans, has announced the introduction of three new health assessments. These are to complement its existing full-body scan, which is popular among celebrities and can detect numerous conditions. The new assessments include a detailed blood test, neurological scan, and a body composition analysis, enhancing the company’s offerings by targeting different health metrics. CEO Andrew Lacy emphasized the emerging demand for preventative and accurate health management solutions, partly due to inadequacies within the traditional health system. Prenuvo reported $100 million in revenue last year and is eyeing expansion both in North America and internationally. To support these initiatives, Prenuvo raised $120 million in a funding round co-led by Left Lane Capital, Forerunner Ventures, and existing investor Felicis Ventures. The funding will aid product expansion, international growth, and the integration of artificial intelligence into Prenuvo's services. Despite criticisms over the price of its offerings, investors remain confident in the startup's trajectory, seeing potential in its large repository of MRI imaging data and its commitment to enhancing diagnostics and health management. The new assessments are initially available at select locations, with plans for wider availability and continued expansion into international markets.

Sectors

  • Healthcare Services
  • Medical Technology
  • Private Equity and Venture Capital

Geography

  • United States – Prenuvo's current services are available in major locations like Silicon Valley, Los Angeles, and New York, indicating a significant focus in the U.S. market.
  • North America – Prenuvo operates 17 clinics across North America, showcasing its existing geographical presence in this region.
  • Europe and Australia – Future expansion plans include new clinics in Europe and Australia, marking potential growth in these regions.

Industry

  • Healthcare Services – Prenuvo operates within the healthcare services industry by providing full-body MRI scans and health assessments to proactively manage and diagnose patient health.
  • Medical Technology – Prenuvo's use of custom FDA-approved MRI machines and AI-driven body composition analysis places it within the medical technology sector.
  • Private Equity and Venture Capital – Involvement of investment firms such as Felicis Ventures, Left Lane Capital, and Forerunner Ventures highlights the participation of the private equity and venture capital sectors.

Financials

  • $120 million – Amount of fresh funding raised in the round co-led by Left Lane Capital, Forerunner Ventures, and Felicis Ventures.
  • $100 million – Revenue generated by Prenuvo in the previous year.
  • $2,500 – Cost of Prenuvo’s original full-body MRI scan.
  • $3,999 – Price for the new bundled health assessments offered by Prenuvo.

Participants

NameRoleTypeDescription
PrenuvoTarget CompanyCompanyPrenuvo is a preventative health company offering full-body MRI scans and new health assessments.
Felicis Ventures LLCInvestorCompanyAn existing investor in Prenuvo, participating in the recent $120 million funding round.
Left Lane CapitalInvestorCompanyA co-lead in the recent funding round supporting Prenuvo’s expansion.
Forerunner VenturesInvestorCompanyTogether with Left Lane Capital and Felicis Ventures, co-led Prenuvo’s funding round.
Andrew LacyCEOPersonCEO of Prenuvo, steering the company’s growth and new service offerings.